Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2013; 19(23): 3583-3595
Published online Jun 21, 2013. doi: 10.3748/wjg.v19.i23.3583
Published online Jun 21, 2013. doi: 10.3748/wjg.v19.i23.3583
Figure 1 Morphology of bone-marrow mesenchymal stem cells in vitro, and in vivo cell tracing of bone-marrow mesenchymal stem cells colonization in rat intestine.
A: First-passage bone-marrow mesenchymal stem cells (BM MSCs); B: Third-passage BM MSCs (× 200); C: Homing of fluorescently labeled BM MSCs (B16-F10-Luc-G5) to the rat intestine 6 h after transplantation; D: After the intestine was removed and washed repeatedly, fluorescently labeled BM MSCs were still observed, confirming the cells homed to the intestine and survived.
-
Citation: Shen ZY, Zhang J, Song HL, Zheng WP. Bone-marrow mesenchymal stem cells reduce rat intestinal ischemia-reperfusion injury, ZO-1 downregulation and tight junction disruption
via a TNF-α-regulated mechanism. World J Gastroenterol 2013; 19(23): 3583-3595 - URL: https://www.wjgnet.com/1007-9327/full/v19/i23/3583.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i23.3583